|
Video: What is a Stock Split?
|
|
Co-Diagnostics develops, manufactures and sells reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Co. may sell diagnostic equipment from other manufacturers as self-contained lab systems. Co. has a portable polymerase chain reaction (PCR) device that is designed to bring PCR to patients in point-of-care and even at-home settings. Co.'s diagnostics systems enable molecular testing for organisms and genetic diseases by automating procedures in both the development and administration of tests. According to our Co-Diagnostics stock split history records, Co-Diagnostics has had 0 splits. | |
|
Co-Diagnostics (CODX) has 0 splits in our Co-Diagnostics stock split history database.
Looking at the Co-Diagnostics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Co-Diagnostics shares, starting with a $10,000 purchase of CODX, presented on a split-history-adjusted basis factoring in the complete Co-Diagnostics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/13/2017 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$5.60 |
|
End price/share: |
$1.19 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-78.75% |
|
Average Annual Total Return: |
-20.35% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,125.80 |
|
Years: |
6.81 |
|
|
|
|
|